Wu et al.[36] and Mikhailov et al.[37] observed that AOPCP, a CD73 enzyme activity inhibitor, could not completely block the effect of CD73 in cell proliferation and TRAIL‐induced apoptosis of cancer cells, respectively, implying an enzyme independent activity of CD73. This evidence concerns the gene TNFSF10 and cancer.